Last update 20 Mar 2025

Huzhen QingFeng Capsule

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms
Huzhen Tongfeng Capsule, 虎贞痛风胶囊, 虎贞通风胶囊
Target-
Action-
Mechanism-
Therapeutic Areas
Congenital DisordersEndocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases+ [1]
Active Indication
Arthritis, Gouty
Inactive Indication-
Originator Organization
Guangdong YILI Pharmaceutical Group Co., Ltd.Guangdong YILI Pharmaceutical Group Co., Ltd.
Active Organization
Guangdong YILI Pharmaceutical Group Co., Ltd.Guangdong YILI Pharmaceutical Group Co., Ltd.
Inactive Organization
Guangzhou Jinan Biological Medicine Research Development Base Co., Ltd.Guangzhou Jinan Biological Medicine Research Development Base Co., Ltd.
Drug Highest PhaseApproved
First Approval Date
China (14 Dec 2021),
Arthritis, Gouty
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Huzhen QingFeng Capsule
CTR20150783
/ CompletedPhase 3
虎贞通风胶囊与安慰剂对照治疗急性通风性关节炎（湿热蕴结症）随机、双盲、多中心临床试验
[Translation] A randomized, double-blind, multicenter clinical trial of Huzhen Tongfeng Capsule versus placebo in the treatment of acute ventilatory arthritis (damp-heat accumulation syndrome)
CTR20131159
/ CompletedNot Applicable
虎贞痛风胶囊与安慰剂对照治疗急性痛风性关节炎 (湿热蕴结证)随机、双盲、多中心临床试验
[Translation] A randomized, double-blind, multicenter clinical trial of Huzhen Tongfeng Capsule versus placebo in the treatment of acute gouty arthritis (damp-heat accumulation syndrome)
100 Clinical Results associated with Huzhen QingFeng Capsule
Login to view more data
100 Translational Medicine associated with Huzhen QingFeng Capsule
Login to view more data
100 Patents (Medical) associated with Huzhen QingFeng Capsule
Login to view more data
100 Deals associated with Huzhen QingFeng Capsule
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Arthritis, Gouty
China
Guangdong YILI Pharmaceutical Group Co., Ltd.Guangdong YILI Pharmaceutical Group Co., Ltd.
14 Dec 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Arthritis, GoutyPhase 3
China
Guangzhou Jinan Biological Medicine Research Development Base Co., Ltd.Guangzhou Jinan Biological Medicine Research Development Base Co., Ltd.
16 Jun 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free